Lmr Partners LLP Sesen Bio, Inc. Transaction History

Lmr Partners LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.38 - $0.89 $36,381 - $85,209	95,741 New	95,741 $78,000
Q2 2021 Aug 16, 2021	SELL	$2.18 - $4.66 $220,166 - $470,632	-100,994 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.3 - $3.24 $116,733 - $290,935	89,795 Added 801.81%	100,994 $263,000
Q4 2020 Feb 16, 2021	BUY	$1.01 - $1.77 $11,310 - $19,822	11,199 New	11,199 $15,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.